Literature DB >> 26948924

Challenges for the new Cancer Drugs Fund.

Peter Littlejohns1, Albert Weale2, Katharina Kieslich1, James Wilson3, Benedict Rumbold3, Catherine Max4, Annette Rid5.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26948924     DOI： 10.1016/S1470-2045(16)00100-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  The New and Non-Transparent Cancer Drugs Fund.

Authors:  Eifiona M Wood; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

2.  National Institute for Health and Care Excellence, social values and healthcare priority setting.

Authors:  Peter Littlejohns; Kalipso Chalkidou; Anthony J Culyer; Albert Weale; Annette Rid; Katharina Kieslich; Clare Coultas; Catherine Max; Jill Manthorpe; Benedict Rumbold; Victoria Charlton; Helen Roberts; Ruth Faden; James Wilson; Carleigh Krubiner; Polly Mitchell; Gry Wester; Jennifer A Whitty; Selena Knight
Journal:  J R Soc Med       Date:  2019-04-02       Impact factor: 5.344

3.  Public values and plurality in health priority setting: What to do when people disagree and why we should care about reasons as well as choices.

Authors:  Rachel Baker; Helen Mason; Neil McHugh; Cam Donaldson
Journal:  Soc Sci Med       Date:  2021-04-02       Impact factor: 4.634

4.  Setting standards and monitoring quality in the NHS 1999-2013: a classic case of goal conflict.

Authors:  Peter Littlejohns; Alec Knight; Anna Littlejohns; Tara-Lynn Poole; Katharina Kieslich
Journal:  Int J Health Plann Manage       Date:  2016-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.